Innovex International financials
$27.41−5.02%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $978.3M | $660.8M |
| Gross profit | $303.3M | $232.6M |
| Gross margin | 31.0% | 35.2% |
| Operating income | $92.8M | $48.4M |
| Net income | $83.3M | $140.3M |
| Net margin | 8.5% | 21.2% |
| Diluted EPS | $1.20 | $2.77 |
| EBITDA | $174.5M | $116.5M |
| Operating cash flow | $190.9M | $93.4M |
| Free cash flow | $155.8M | $79.8M |
| Diluted shares | 69.4M | 50.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $203.4M | $73.3M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $25.6M | $35.4M |
| Total assets | $1.27B | $1.20B |
| Total liabilities | $210.6M | $239.3M |
| Shareholders' equity | $1.06B | $958.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology